GH Guardant Health Inc

Ownership history in SWS Partners  ·  16 quarters on record

This page tracks every 13F SEC filing in which SWS Partners reported a position in Guardant Health Inc (GH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.9% (2025 Q4)
Avg. % of fund
0.82%
First filed
2022 Q1
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 77,209 -17,347 -18.3% 1.90% $7.9M $102.14
2025 Q3 ADDED 94,556 +1,479 +1.6% 1.44% $5.9M $62.48
2025 Q2 REDUCED 93,077 -27,811 -23.0% 1.31% $4.8M $52.04
2025 Q1 UNCHANGED 120,888 0% 1.12% $3.7M $42.60
2024 Q4 ADDED 120,888 +37,126 +44.3% 1.12% $3.7M $30.55
2024 Q3 ADDED 83,762 +4,905 +6.2% 0.61% $1.9M $22.94
2024 Q2 ADDED 78,857 +33,446 +73.7% 0.68% $2.3M $28.88
2024 Q1 REDUCED 45,411 -560 -1.2% 0.28% $937K $20.63
2023 Q4 REDUCED 45,971 -724 -1.6% 0.41% $1.2M $27.05
2023 Q3 ADDED 46,695 +2,663 +6.0% 0.51% $1.4M $29.64
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GH price (monthly, adj. close)
← Back to SWS Partners Holdings